 BOSTON , June 10, 2022 PRNewswire -- Ginkgo Bioworks NYSE: DNA, the leading horizontal platform for cell programming, announced today that management is scheduled to participate in Goldman Sachs 43rd Annual Global Healthcare Conference, on June 15, 2022, at 10:40 a.m. PT. Further details, a webcast link, and a replay of the presentation, if available, will be posted on the companys investor relations website at 